155 related articles for article (PubMed ID: 37533043)
1. Sabin polio virus protein 1 (VP1) evolution in patients with acute flaccid paralysis from 2010 to 2016 in Uganda.
Nanteza MB; Bakamutumaho B; Tushabe P; Namuwulya P; Birungi M; Dhatemwa R; Eliku JP; Tibanagwa M; Kakooza P; Bukenya H; Bwogi J; Byabamazima CR
Virol J; 2023 Aug; 20(1):172. PubMed ID: 37533043
[TBL] [Abstract][Full Text] [Related]
2. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of the acute flaccid paralysis surveillance system for poliovirus in South Africa, 2016-2019.
Howard W; Moonsamy S; Seakamela L; Jallow S; Modiko F; du Plessis H; Sibiya R; Kamupira M; Maseti E; Suchard M
J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34672918
[No Abstract] [Full Text] [Related]
4. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
[TBL] [Abstract][Full Text] [Related]
5. Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda.
Tushabe P; Bwogi J; Eliku JP; Aine F; Birungi M; Gaizi J; Nakabazzi L; Kabaliisa T; Turyahabwe I; Namuwulya P; Nanteza MB; Bukenya H; Kanyesigye C; Katushabe E; Ampeire I; Kisakye A; Bakamutumaho B; Byabamazima CR
Arch Virol; 2023 Apr; 168(5):140. PubMed ID: 37059887
[TBL] [Abstract][Full Text] [Related]
6. Sporadic isolation of sabin-like polioviruses and high-level detection of non-polio enteroviruses during sewage surveillance in seven Italian cities, after several years of inactivated poliovirus vaccination.
Battistone A; Buttinelli G; Fiore S; Amato C; Bonomo P; Patti AM; Vulcano A; Barbi M; Binda S; Pellegrinelli L; Tanzi ML; Affanni P; Castiglia P; Germinario C; Mercurio P; Cicala A; Triassi M; Pennino F; Fiore L
Appl Environ Microbiol; 2014 Aug; 80(15):4491-501. PubMed ID: 24814793
[TBL] [Abstract][Full Text] [Related]
7. The road to a polio-free Uganda; contribution of the Expanded Program on Immunization Laboratory (EPI-LAB) at Uganda Virus Research Institute.
Nanteza MB; Tushabe P; Bukenya H; Namuwulya P; Kabaliisa T; Birungi M; Tibanagwa M; Ampeire I; Kakooza P; Katushabe E; Bwogi J; Bakamutumaho B; Nanyunja M; Byabamazima CR
Afr Health Sci; 2023 Sep; 23(3):186-196. PubMed ID: 38357183
[TBL] [Abstract][Full Text] [Related]
8. Environmental Surveillance Complements Case-Based Surveillance of Acute Flaccid Paralysis in Polio Endgame Strategy 2019-2023.
Chen P; Liu Y; Wang H; Liu G; Lin X; Zhang W; Ji F; Xu Q; Tao Z; Xu A
Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32444474
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
[TBL] [Abstract][Full Text] [Related]
10. Genetic landscape and macro-evolution of co-circulating Coxsackieviruses A and Vaccine-derived Polioviruses in the Democratic Republic of Congo, 2008-2013.
Sadeuh-Mba SA; Kavunga-Membo H; Joffret ML; Yogolelo R; Endegue-Zanga MC; Bessaud M; Njouom R; Muyembe-Tamfu JJ; Delpeyroux F
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007335. PubMed ID: 31002713
[TBL] [Abstract][Full Text] [Related]
11. The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda.
Nanteza MB; Bakamutumaho B; Kisakye A; Namuwulya P; Bukenya H; Katushabe E; Bwogi J; Byabamazima CR; Williams R; Gumede N
Virol J; 2018 Apr; 15(1):77. PubMed ID: 29699577
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status.
Wang HB; Luo HM; Li L; Fan CX; Hao LX; Ma C; Su QR; Yang H; Reilly KH; Wang HQ; Wen N
BMC Infect Dis; 2017 Dec; 17(1):742. PubMed ID: 29197328
[TBL] [Abstract][Full Text] [Related]
13. Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
Martin J; Burns CC; Jorba J; Shulman LM; Macadam A; Klapsa D; Majumdar M; Bullows J; Frolov A; Mate R; Bujaki E; Castro CJ; Bullard K; Konz J; Hawes K; Gauld J; Blake IM; Mercer LD; Kurji F; Voorman A; Diop OM; Oberste MS; Modlin J; Macklin G; Eisenhawer M; Bandyopadhyay AS; Zipursky S
MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(24):786-790. PubMed ID: 35709073
[TBL] [Abstract][Full Text] [Related]
14. Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021.
Yang H; Qi Q; Zhang Y; Wen N; Cao L; Liu Y; Fan C; Yan D; Zhu X; Hao L; Zhu S; Ma Q; Liu J; Ma C; Nan L; Chen Y; Ma X; Chen N; Deng K; Shao G; Ding X; An Z; Rodewald LE; Li X; Wang D; Zhu H; Wang H; Feng Z; Xu W; Zhou J; Yin Z;
JAMA Netw Open; 2023 Jan; 6(1):e2249710. PubMed ID: 36602797
[TBL] [Abstract][Full Text] [Related]
15. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region.
Arita M; Zhu SL; Yoshida H; Yoneyama T; Miyamura T; Shimizu H
J Virol; 2005 Oct; 79(20):12650-7. PubMed ID: 16188967
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological survey and genetic characterization of type 3 vaccine-derived poliovirus isolated from a patient with four doses of inactivated polio vaccine in Henan Province, China.
Zhang M; Yang J; Bai Y; Zhu H; Wang C; Zhang L; Xu J; Lu M; Zhang X; Xiao Z; Ma Y; Wang Y; Li X; Wang D; Zhu S; Yan D; Xu W; Zhang Y; Zhang Y
Infect Dis Poverty; 2022 Dec; 11(1):124. PubMed ID: 36514167
[TBL] [Abstract][Full Text] [Related]
17. Circulating vaccine-derived polioviruses in the Extreme North region of Cameroon.
Endegue-Zanga MC; Sadeuh-Mba SA; Iber J; Burns C; Nimpa-Mengouo M; Demanou M; Vernet G; Etoa FX; Njouom R
J Clin Virol; 2015 Jan; 62():80-3. PubMed ID: 25542478
[TBL] [Abstract][Full Text] [Related]
18. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.
Rahimi P; Tabatabaie H; Gouya MM; Zahraie M; Mahmudi M; Ziaie A; Rad KS; Shahmahmudi Sh; Musavi T; Azad TM; Nategh R
J Clin Virol; 2007 Aug; 39(4):304-7. PubMed ID: 17590391
[TBL] [Abstract][Full Text] [Related]
19. Sabin and wild type polioviruses from children who presented with acute flaccid paralysis in Nigeria.
Adedeji AO; Okonko IO; Adu FD
Afr Health Sci; 2012 Sep; 12(3):345-54. PubMed ID: 23382751
[TBL] [Abstract][Full Text] [Related]
20. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
